Nian Huang

Nian Huang

Auto-generated profile, based on publicly available information

Nian Huang

Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2015 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
Shuang YangShuang Yang
Shuang Yang
NHNian Huang
Nian Huang
YJYong Mei Jin
Yong Mei Jin
HZHui Qing Zhang
Hui Qing Zhang
YSYong Hua Su
Yong Hua Su
HYHua Gui Yang
Hua Gui Yang
We highlight the crystal shape engineering of anatase TiO 2 from thermodynamics, kinetics and bio-inspired perspectives and its success in biomedical applications.

1 May 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YSYonghua Su
Yonghua Su
NHNian Huang
Nian Huang
DCDi Chen
Di Chen
LZLi Zhang
Li Zhang
XDXia Dong
Xia Dong
CLChangquan Ling
Changquan Ling
The Chinese traditional medicine Shikonin is an ideal drug due to its multiple targets to tumor cells. But in clinics, improving its aqueous solubility and tumor accumulation is still a challenge. Herein, a copolymer with tunable poly(N-isopropylacrymaide) and polylactic acid block lengths is designed, synthesized, and characterized in nuclear magnetic resonance. The corresponding thermosensitive nanomicelle (TN) with well-defined core-shell structure is then assembled in an aqueous solution. For promoting the therapeutic index, the physical-chemistry properties of TNs including narrow size, low critical micellar concentration, high serum stability, tunable volume phase transition temperature (VPTT), high drug-loading capacity, and temperature-controlled drug release are systematically investigated and regulated through the fine self-assembly. The shikonin is then entrapped in a degradable inner core resulting in a shikonin-loaded thermosensitive nanomicelle (STN) with a VPTT of ~40°C. Compared with small-molecular shikonin, the in vitro cellular internalization and cytotoxicity of STN against breast cancer cells (Michigan Cancer Foundation-7) are obviously enhanced. In addition, the therapeutic effect is further enhanced by the programmed cell death (PCD) specifically evoked by shikonin. Interestingly, both the proliferation inhibition and PCD are synergistically promoted as T > VPTT, namely the temperature-regulated passive targeting. Consequently, as intravenous injection is administered to the BALB/c nude mice bearing breast cancer, the intra-tumor accumulation of STNs is significantly increased as T > VPTT, which is regulated by the in-house developed heating device. The in vivo antitumor assays against breast cancer further confirm the synergistically enhanced therapeutic efficiency. The findings of this study indicate that STN is a potential effective nanoformulation in clinical cancer therapy.

28 June 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HZHuiqing Zhang
Huiqing Zhang
NHNian Huang
Nian Huang
GYGeliang Yang
Geliang Yang
QLQing Lin
Qing Lin
YSYonghua Su
Yonghua Su
Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution